Fractyl Health reported cash from operations of -$15.90M and free cash flow of -$15.90M for the quarter ended Jun 2026, up 25.0% year over year. This cash flow statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Net Income | -11.69M | -11.72M | -13.65M | -12.52M | -20.44M | -21.61M | -22.85M | -24.48M | -24.26M | -25.85M | -22.53M | -22.64M | -20.23M | -18.66M |
| Share-based Compensation | 0.86M | 1.07M | 1.09M | 1.28M | 5.22M | 3.79M | 2.52M | 2.90M | 1.41M | 1.78M | 1.64M | 1.85M | 2.53M | 2.50M |
| Gains from Investment Securities | 0.01M | 0.13M | 1.03M | 5.63M | -10.45M | -4.70M | -2.29M | -0.47M | -0.82M | 0.35M | 21.20M | -24.51M | -30.05M | 5.48M |
| Cash from Operations | -9.55M | -11.66M | -11.02M | -10.60M | -11.71M | -18.74M | -18.04M | -17.03M | -25.08M | -21.20M | -22.71M | -21.34M | -22.48M | -15.90M |
| Depreciation, Depletion & Amortization | ||||||||||||||
| Amortization of Deferred Charges | 0.03M | |||||||||||||
| Change in Working Capital | ||||||||||||||
| Change in Receivables | 0.01M | 0.05M | -0.03M | -0.00M | -0.01M | |||||||||
| Change in Inventory | 0.07M | 0.00M | -0.00M | -0.07M | ||||||||||
| Change in Account Payables | -0.22M | -0.21M | -0.07M | 0.08M | 0.49M | 1.04M | -0.35M | 1.50M | -1.76M | 2.43M | -2.65M | 0.32M | 0.07M | -0.64M |
| Change in Accured Expenses | 0.96M | -0.87M | 0.08M | 0.37M | 2.85M | -1.79M | 1.97M | 2.62M | 0.78M | 0.61M | -0.81M | -0.17M | -2.93M | 1.04M |
| Other Working Capital Changes | -0.71M | -0.06M | 0.30M | 1.03M | 0.60M | 1.09M | -0.31M | 0.82M | 0.67M | -1.27M | -1.57M | -0.07M | 0.77M | -1.54M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | 0.02M | 0.06M | 0.15M | 0.14M | 1.06M | 0.26M | 0.21M | 0.23M | 0.45M | 0.10M | 0.01M | 0.00M | ||
| Cash from Investing Activities | -0.02M | -0.06M | -0.15M | -0.14M | -1.06M | -0.26M | -0.21M | -0.23M | -0.45M | -0.10M | -0.01M | -0.00M | ||
| Financing Activities | ||||||||||||||
| Other financing activities | 0.01M | 0.02M | 103.69M | 0.28M | 19.46M | 4.06M | ||||||||
| Change in Capital Stock | ||||||||||||||
| Net Shares Issued and Repurchased | 2.14M | 3.13M | 2.11M | 3.25M | ||||||||||
| Net Equity Issued and Repurchased | 0.48M | 4.71M | 0.17M | |||||||||||
| Misc. | ||||||||||||||
| Cash from Financing Activities | -0.00M | 0.03M | 27.97M | -0.56M | 101.00M | -0.01M | 0.16M | 0.07M | 0.17M | 1.48M | 78.09M | 25.22M | 4.11M | -0.13M |
| Change in Cash | -9.57M | -11.68M | 16.80M | -11.29M | 88.23M | -19.00M | -18.09M | -17.20M | -25.36M | -19.82M | 55.37M | 3.88M | -18.37M | -16.03M |
| Free Cash Flow | -9.57M | -11.71M | -11.17M | -10.73M | -12.77M | -19.00M | -18.25M | -17.27M | -25.53M | -21.30M | -22.72M | -21.34M | -22.48M | -15.90M |
| Net Cash Flow | -9.57M | -11.68M | 16.80M | -11.29M | 88.23M | -19.00M | -18.09M | -17.20M | -25.36M | -19.82M | 55.37M | 3.88M | -18.37M | -16.03M |